A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone
B. Haab, L. Qian, B. Staal, M. Jain, J. F. Fahrmann, C. Worthington, D. Prosser, L. Velikokhatnaya, C. Lopez, R. Tang, M. Hurd, N. Gopalakrishnan, S. Kumar, L. Smith, S. Hanash, , R. Brand
This study evaluates combinations of PDAC biomarkers across multiple labs, finding improved sensitivity and specificity for early-stage detection compared to CA19-9 alone.
bioRxiv · May 22, 2024Cancer Biology